Factors Associated with Response to Acetylcholinesterase Inhibition in Dementia: A Cohort Study from a Secondary Mental Health Care Case Register in London

Predictors of Placebo Group Decline in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in 24 Week Clinical Trials of Alzheimer's Disease

(2017) Michael C. Irizarry et al.   JOURNAL OF ALZHEIMERS DISEASE

Prevalence of dementia in African–Caribbean compared with UK-born White older people: two-stage cross-sectional study

(2011) Simon Adelman et al.   BRITISH JOURNAL OF PSYCHIATRY

Associations between substance use disorder sub-groups, life expectancy and all-cause mortality in a large British specialist mental healthcare service

(2011) Richard D. Hayes et al.   DRUG AND ALCOHOL DEPENDENCE

Predicting cognitive decline in Alzheimer's disease: An integrated analysis

(2010) Oscar L. Lopez et al.   Alzheimers & Dementia

Effects of Donepezil, Galantamine and Rivastigmine in 938 Italian Patients with Alzheimerʼs Disease

(2010) Aurelia Santoro et al.   CNS DRUGS

ORIGINAL ARTICLE: Investigation of responders and non-responders to long-term donepezil treatment

(2010) Jun INOUE et al.   Psychogeriatrics

Donepezil provides greater benefits in mild compared to moderate Alzheimer's disease: Implications for early diagnosis and treatment

(2009) J.L. Molinuevo et al.   ARCHIVES OF GERONTOLOGY AND GERIATRICS

The South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register: development and descriptive data

(2009) Robert Stewart et al.   BMC Psychiatry

Predictors of progression of cognitive decline in Alzheimer’s disease: the role of vascular and sociodemographic factors

(2009) Massimo Musicco et al.   JOURNAL OF NEUROLOGY

Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline

(2008) Paul K. Crane et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY